Skip to main content

PLEASE NOTE: For everyone’s safety, Fasken recommends anyone on-site at our Canadian offices be familiar with the COVID-19 recommendations in place which may include one or more of the following: social distancing, hand sanitizing, wearing a mask in common areas and proof of full vaccination. These measures apply to lawyers, staff, clients, service providers and other visitors.

Client Work

Concordia Healthcare completes qualifying transaction

Reading Time 1 minute read Subscribe



Concordia Healthcare Corp.

On December 23, 2013, Concordia Healthcare Corp. (“Concordia”), formerly named Mercari Acquisition Corp., announced the completion of a qualifying transaction (the “Transaction”) pursuant to Policy 2.4 – Capital Pool Companies of the TSX Venture Exchange. Pursuant to the Transaction, Concordia Healthcare Inc. (“CHI”) amalgamated with Concordia’s wholly-owned subsidiary, Mercari Subco Inc., in accordance with an amalgamation agreement dated December 13, 2013, and Concordia acquired all of the issued and outstanding common shares of CHI in exchange for the issuance of Concordia common shares to previous CHI shareholders on the basis of one CHI share for one Concordia share. The common shares of Concordia are listed for trading on the Toronto Stock Exchange under the symbol “CXR”. Concordia was advised in this transaction by a team from Fasken Martineau DuMoulin LLP that included, among others, Rubin Rapuch, Tracy Hooey, Francesco Tallarico and Will Shaw (corporate/securities) and Mitchell Thaw (tax).



    Receive email updates from our team